{"id": "train_8_156", "text": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the @GENE$ genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and @DISEASE$.", "text_with_entity_marker": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the [E1]@GENE$[/E1] genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the [GENE]@GENE$[/GENE] genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [101, 107], "entity_1_idx_in_text_with_entity_marker": [105, 111], "entity_1_idx_in_text_with_typed_entity_marker": [107, 113], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [214, 223], "entity_2_idx_in_text_with_entity_marker": [227, 236], "entity_2_idx_in_text_with_typed_entity_marker": [236, 245], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_268", "text": "Especially, the SNP @GENE$ and its strongly associated SNPs (e.g., rs1784235) could be important to human @DISEASE$ phenotypes.", "text_with_entity_marker": "Especially, the SNP [E1]@GENE$[/E1] and its strongly associated SNPs (e.g., rs1784235) could be important to human [E2]@DISEASE$[/E2] phenotypes.", "text_with_typed_entity_marker": "Especially, the SNP [GENE]@GENE$[/GENE] and its strongly associated SNPs (e.g., rs1784235) could be important to human [DISEASE]@DISEASE$[/DISEASE] phenotypes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [106, 115], "entity_2_idx_in_text_with_entity_marker": [119, 128], "entity_2_idx_in_text_with_typed_entity_marker": [128, 137], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_304", "text": "Lack of association between @GENE$ and NOS1AP rs7538490 and type 2 diabetes, @DISEASE$, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_entity_marker": "Lack of association between [E1]@GENE$[/E1] and NOS1AP rs7538490 and type 2 diabetes, [E2]@DISEASE$[/E2], obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_typed_entity_marker": "Lack of association between [GENE]@GENE$[/GENE] and NOS1AP rs7538490 and type 2 diabetes, [DISEASE]@DISEASE$[/DISEASE], obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [77, 86], "entity_2_idx_in_text_with_entity_marker": [90, 99], "entity_2_idx_in_text_with_typed_entity_marker": [99, 108], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_242", "text": "Lack of association between PKLR rs3020781 and @GENE$ and type 2 diabetes, @DISEASE$, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_entity_marker": "Lack of association between PKLR rs3020781 and [E1]@GENE$[/E1] and type 2 diabetes, [E2]@DISEASE$[/E2], obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_typed_entity_marker": "Lack of association between PKLR rs3020781 and [GENE]@GENE$[/GENE] and type 2 diabetes, [DISEASE]@DISEASE$[/DISEASE], obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [47, 53], "entity_1_idx_in_text_with_entity_marker": [51, 57], "entity_1_idx_in_text_with_typed_entity_marker": [53, 59], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [75, 84], "entity_2_idx_in_text_with_entity_marker": [88, 97], "entity_2_idx_in_text_with_typed_entity_marker": [97, 106], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_109", "text": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of @DISEASE$ and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a @GENE$-dependent disease risk factor.", "text_with_entity_marker": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of [E1]@DISEASE$[/E1] and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a [E2]@GENE$[/E2]-dependent disease risk factor.", "text_with_typed_entity_marker": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of [DISEASE]@DISEASE$[/DISEASE] and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a [GENE]@GENE$[/GENE]-dependent disease risk factor.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [95, 104], "entity_1_idx_in_text_with_entity_marker": [99, 108], "entity_1_idx_in_text_with_typed_entity_marker": [104, 113], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [196, 202], "entity_2_idx_in_text_with_entity_marker": [209, 215], "entity_2_idx_in_text_with_typed_entity_marker": [221, 227], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_8_114", "text": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and @GENE$, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.", "text_with_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and [E1]@GENE$[/E1], in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and [GENE]@GENE$[/GENE], in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [73, 79], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_idx_in_text_with_typed_entity_marker": [79, 85], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [325, 334], "entity_2_idx_in_text_with_entity_marker": [338, 347], "entity_2_idx_in_text_with_typed_entity_marker": [347, 356], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_153", "text": "The @GENE$ gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (@DISEASE$) in the Japanese population.", "text_with_entity_marker": "The [E1]@GENE$[/E1] gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms ([E2]@DISEASE$[/E2]) in the Japanese population.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms ([DISEASE]@DISEASE$[/DISEASE]) in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [96, 105], "entity_2_idx_in_text_with_entity_marker": [109, 118], "entity_2_idx_in_text_with_typed_entity_marker": [118, 127], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_208", "text": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to @DISEASE$ (CD) risk in general and of the @GENE$ variant in particular.", "text_with_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to [E1]@DISEASE$[/E1] (CD) risk in general and of the [E2]@GENE$[/E2] variant in particular.", "text_with_typed_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to [DISEASE]@DISEASE$[/DISEASE] (CD) risk in general and of the [GENE]@GENE$[/GENE] variant in particular.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [102, 111], "entity_1_idx_in_text_with_entity_marker": [106, 115], "entity_1_idx_in_text_with_typed_entity_marker": [111, 120], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [144, 150], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_idx_in_text_with_typed_entity_marker": [169, 175], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_8_155", "text": "Women carrying homozygous @GENE$ genotypes had a significantly decreased risk of cervical or @DISEASE$ compared to His1104Asp or His1104His genotypes.", "text_with_entity_marker": "Women carrying homozygous [E1]@GENE$[/E1] genotypes had a significantly decreased risk of cervical or [E2]@DISEASE$[/E2] compared to His1104Asp or His1104His genotypes.", "text_with_typed_entity_marker": "Women carrying homozygous [GENE]@GENE$[/GENE] genotypes had a significantly decreased risk of cervical or [DISEASE]@DISEASE$[/DISEASE] compared to His1104Asp or His1104His genotypes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [26, 32], "entity_1_idx_in_text_with_entity_marker": [30, 36], "entity_1_idx_in_text_with_typed_entity_marker": [32, 38], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [93, 102], "entity_2_idx_in_text_with_entity_marker": [106, 115], "entity_2_idx_in_text_with_typed_entity_marker": [115, 124], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_255", "text": "We genotyped the four single-nucleotide polymorphisms (rs706778, @GENE$, ss52580101, and rs11594656) of the IL2RA in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.", "text_with_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, [E1]@GENE$[/E1], ss52580101, and rs11594656) of the IL2RA in 885 patients with [E2]@DISEASE$[/E2] and 606 control subjects of Japanese origin.", "text_with_typed_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, [GENE]@GENE$[/GENE], ss52580101, and rs11594656) of the IL2RA in 885 patients with [DISEASE]@DISEASE$[/DISEASE] and 606 control subjects of Japanese origin.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [135, 144], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_idx_in_text_with_typed_entity_marker": [157, 166], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_246", "text": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of @GENE$ but protects against @DISEASE$.", "text_with_entity_marker": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of [E1]@GENE$[/E1] but protects against [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of [GENE]@GENE$[/GENE] but protects against [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [97, 103], "entity_1_idx_in_text_with_entity_marker": [101, 107], "entity_1_idx_in_text_with_typed_entity_marker": [103, 109], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [125, 134], "entity_2_idx_in_text_with_entity_marker": [138, 147], "entity_2_idx_in_text_with_typed_entity_marker": [147, 156], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_218", "text": "In the independent trio samples, @GENE$ and rs677221-G consistently showed significant under-transmission to @DISEASE$ offspring (unadjusted p = .003 and p = .004, respectively).", "text_with_entity_marker": "In the independent trio samples, [E1]@GENE$[/E1] and rs677221-G consistently showed significant under-transmission to [E2]@DISEASE$[/E2] offspring (unadjusted p = .003 and p = .004, respectively).", "text_with_typed_entity_marker": "In the independent trio samples, [GENE]@GENE$[/GENE] and rs677221-G consistently showed significant under-transmission to [DISEASE]@DISEASE$[/DISEASE] offspring (unadjusted p = .003 and p = .004, respectively).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [33, 39], "entity_1_idx_in_text_with_entity_marker": [37, 43], "entity_1_idx_in_text_with_typed_entity_marker": [39, 45], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [109, 118], "entity_2_idx_in_text_with_entity_marker": [122, 131], "entity_2_idx_in_text_with_typed_entity_marker": [131, 140], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_243", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, @GENE$, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, [E2]@GENE$[/E2], ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, [GENE]@GENE$[/GENE], ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [628, 634], "entity_2_idx_in_text_with_entity_marker": [641, 647], "entity_2_idx_in_text_with_typed_entity_marker": [653, 659], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_8_194", "text": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, @GENE$, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, [E1]@GENE$[/E1], rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, [GENE]@GENE$[/GENE], rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [91, 97], "entity_1_idx_in_text_with_entity_marker": [95, 101], "entity_1_idx_in_text_with_typed_entity_marker": [97, 103], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_170", "text": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of @DISEASE$ and intestinal cancer in @GENE$ and GPx2 double knockout mice.", "text_with_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of [E1]@DISEASE$[/E1] and intestinal cancer in [E2]@GENE$[/E2] and GPx2 double knockout mice.", "text_with_typed_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of [DISEASE]@DISEASE$[/DISEASE] and intestinal cancer in [GENE]@GENE$[/GENE] and GPx2 double knockout mice.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [94, 103], "entity_1_idx_in_text_with_entity_marker": [98, 107], "entity_1_idx_in_text_with_typed_entity_marker": [103, 112], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [129, 135], "entity_2_idx_in_text_with_entity_marker": [142, 148], "entity_2_idx_in_text_with_typed_entity_marker": [154, 160], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_8_239", "text": "Ala394Thr polymorphism in the clock gene @GENE$: a circadian modifier for the risk of @DISEASE$.", "text_with_entity_marker": "Ala394Thr polymorphism in the clock gene [E1]@GENE$[/E1]: a circadian modifier for the risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Ala394Thr polymorphism in the clock gene [GENE]@GENE$[/GENE]: a circadian modifier for the risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [41, 47], "entity_1_idx_in_text_with_entity_marker": [45, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 53], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [86, 95], "entity_2_idx_in_text_with_entity_marker": [99, 108], "entity_2_idx_in_text_with_typed_entity_marker": [108, 117], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_118", "text": "Thus, @GENE$ may prevent undue responses to inflammatory stimuli and, in consequence, inflammation-driven initiation of @DISEASE$.", "text_with_entity_marker": "Thus, [E1]@GENE$[/E1] may prevent undue responses to inflammatory stimuli and, in consequence, inflammation-driven initiation of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Thus, [GENE]@GENE$[/GENE] may prevent undue responses to inflammatory stimuli and, in consequence, inflammation-driven initiation of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [6, 12], "entity_1_idx_in_text_with_entity_marker": [10, 16], "entity_1_idx_in_text_with_typed_entity_marker": [12, 18], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [120, 129], "entity_2_idx_in_text_with_entity_marker": [133, 142], "entity_2_idx_in_text_with_typed_entity_marker": [142, 151], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_133", "text": "Identification and replication of three novel @DISEASE$ common susceptibility gene loci on chromosome @GENE$ using linkage and linkage disequilibrium mapping.", "text_with_entity_marker": "Identification and replication of three novel [E1]@DISEASE$[/E1] common susceptibility gene loci on chromosome [E2]@GENE$[/E2] using linkage and linkage disequilibrium mapping.", "text_with_typed_entity_marker": "Identification and replication of three novel [DISEASE]@DISEASE$[/DISEASE] common susceptibility gene loci on chromosome [GENE]@GENE$[/GENE] using linkage and linkage disequilibrium mapping.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [46, 55], "entity_1_idx_in_text_with_entity_marker": [50, 59], "entity_1_idx_in_text_with_typed_entity_marker": [55, 64], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [102, 108], "entity_2_idx_in_text_with_entity_marker": [115, 121], "entity_2_idx_in_text_with_typed_entity_marker": [127, 133], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_8_202", "text": "Our results suggested that common genetic variants in @GENE$ may modulate the risk of developing @DISEASE$ in the study population, particularly in non-smokers.", "text_with_entity_marker": "Our results suggested that common genetic variants in [E1]@GENE$[/E1] may modulate the risk of developing [E2]@DISEASE$[/E2] in the study population, particularly in non-smokers.", "text_with_typed_entity_marker": "Our results suggested that common genetic variants in [GENE]@GENE$[/GENE] may modulate the risk of developing [DISEASE]@DISEASE$[/DISEASE] in the study population, particularly in non-smokers.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [54, 60], "entity_1_idx_in_text_with_entity_marker": [58, 64], "entity_1_idx_in_text_with_typed_entity_marker": [60, 66], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [97, 106], "entity_2_idx_in_text_with_entity_marker": [110, 119], "entity_2_idx_in_text_with_typed_entity_marker": [119, 128], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_259", "text": "The lysyl oxidase-like protein 1 (@GENE$) gene is strongly associated with @DISEASE$, which is very rare in the Chinese population.", "text_with_entity_marker": "The lysyl oxidase-like protein 1 ([E1]@GENE$[/E1]) gene is strongly associated with [E2]@DISEASE$[/E2], which is very rare in the Chinese population.", "text_with_typed_entity_marker": "The lysyl oxidase-like protein 1 ([GENE]@GENE$[/GENE]) gene is strongly associated with [DISEASE]@DISEASE$[/DISEASE], which is very rare in the Chinese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [34, 40], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_idx_in_text_with_typed_entity_marker": [40, 46], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [75, 84], "entity_2_idx_in_text_with_entity_marker": [88, 97], "entity_2_idx_in_text_with_typed_entity_marker": [97, 106], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_28", "text": "@DISEASE$ is associated with decreased expression of mucosal @GENE$.", "text_with_entity_marker": "[E1]@DISEASE$[/E1] is associated with decreased expression of mucosal [E2]@GENE$[/E2].", "text_with_typed_entity_marker": "[DISEASE]@DISEASE$[/DISEASE] is associated with decreased expression of mucosal [GENE]@GENE$[/GENE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [0, 9], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_idx_in_text_with_typed_entity_marker": [9, 18], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [61, 67], "entity_2_idx_in_text_with_entity_marker": [74, 80], "entity_2_idx_in_text_with_typed_entity_marker": [86, 92], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_8_161", "text": "We conclude that stx genotype is one of the important factors of clinical outcome of @DISEASE$ and that pathogenicity for humans was higher in the @GENE$ genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.", "text_with_entity_marker": "We conclude that stx genotype is one of the important factors of clinical outcome of [E1]@DISEASE$[/E1] and that pathogenicity for humans was higher in the [E2]@GENE$[/E2] genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.", "text_with_typed_entity_marker": "We conclude that stx genotype is one of the important factors of clinical outcome of [DISEASE]@DISEASE$[/DISEASE] and that pathogenicity for humans was higher in the [GENE]@GENE$[/GENE] genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [85, 94], "entity_1_idx_in_text_with_entity_marker": [89, 98], "entity_1_idx_in_text_with_typed_entity_marker": [94, 103], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [147, 153], "entity_2_idx_in_text_with_entity_marker": [160, 166], "entity_2_idx_in_text_with_typed_entity_marker": [172, 178], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_8_38", "text": "Compared to the most common @GENE$ haplotype CCAG, the haplotype TTGC conferred an increased risk of @DISEASE$ (OR 1.26, 95% CI 1.04-1.52).", "text_with_entity_marker": "Compared to the most common [E1]@GENE$[/E1] haplotype CCAG, the haplotype TTGC conferred an increased risk of [E2]@DISEASE$[/E2] (OR 1.26, 95% CI 1.04-1.52).", "text_with_typed_entity_marker": "Compared to the most common [GENE]@GENE$[/GENE] haplotype CCAG, the haplotype TTGC conferred an increased risk of [DISEASE]@DISEASE$[/DISEASE] (OR 1.26, 95% CI 1.04-1.52).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [101, 110], "entity_2_idx_in_text_with_entity_marker": [114, 123], "entity_2_idx_in_text_with_typed_entity_marker": [123, 132], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_157", "text": "Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the @GENE$ ligand, muramyl dipeptide, was impaired significantly in @DISEASE$ patients.", "text_with_entity_marker": "Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the [E1]@GENE$[/E1] ligand, muramyl dipeptide, was impaired significantly in [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the [GENE]@GENE$[/GENE] ligand, muramyl dipeptide, was impaired significantly in [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [100, 106], "entity_1_idx_in_text_with_entity_marker": [104, 110], "entity_1_idx_in_text_with_typed_entity_marker": [106, 112], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [164, 173], "entity_2_idx_in_text_with_entity_marker": [177, 186], "entity_2_idx_in_text_with_typed_entity_marker": [186, 195], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_198", "text": "In case-control samples, two SNPs (rs1937970 and @GENE$) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for @DISEASE$ (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_entity_marker": "In case-control samples, two SNPs (rs1937970 and [E1]@GENE$[/E1]) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for [E2]@DISEASE$[/E2] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_typed_entity_marker": "In case-control samples, two SNPs (rs1937970 and [GENE]@GENE$[/GENE]) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for [DISEASE]@DISEASE$[/DISEASE] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [49, 55], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_idx_in_text_with_typed_entity_marker": [55, 61], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_23", "text": "However, the majority of @DISEASE$ cells have deregulation of the @GENE$/beta-catenin pathway.", "text_with_entity_marker": "However, the majority of [E1]@DISEASE$[/E1] cells have deregulation of the [E2]@GENE$[/E2]/beta-catenin pathway.", "text_with_typed_entity_marker": "However, the majority of [DISEASE]@DISEASE$[/DISEASE] cells have deregulation of the [GENE]@GENE$[/GENE]/beta-catenin pathway.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [25, 34], "entity_1_idx_in_text_with_entity_marker": [29, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 43], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [66, 72], "entity_2_idx_in_text_with_entity_marker": [79, 85], "entity_2_idx_in_text_with_typed_entity_marker": [91, 97], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_8_112", "text": "We observed that the @GENE$ allele is associated with @DISEASE$ susceptibility either in the case-control or in the meta-analysis studies.", "text_with_entity_marker": "We observed that the [E1]@GENE$[/E1] allele is associated with [E2]@DISEASE$[/E2] susceptibility either in the case-control or in the meta-analysis studies.", "text_with_typed_entity_marker": "We observed that the [GENE]@GENE$[/GENE] allele is associated with [DISEASE]@DISEASE$[/DISEASE] susceptibility either in the case-control or in the meta-analysis studies.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [21, 27], "entity_1_idx_in_text_with_entity_marker": [25, 31], "entity_1_idx_in_text_with_typed_entity_marker": [27, 33], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [54, 63], "entity_2_idx_in_text_with_entity_marker": [67, 76], "entity_2_idx_in_text_with_typed_entity_marker": [76, 85], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_125", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and @GENE$, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and [E2]@GENE$[/E2], conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and [GENE]@GENE$[/GENE], conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [479, 485], "entity_2_idx_in_text_with_entity_marker": [492, 498], "entity_2_idx_in_text_with_typed_entity_marker": [504, 510], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_8_249", "text": "@GENE$ genotyping might make tailor chemotherapy possible for @DISEASE$ patients treated with oxaliplatin-based chemotherapy.", "text_with_entity_marker": "[E1]@GENE$[/E1] genotyping might make tailor chemotherapy possible for [E2]@DISEASE$[/E2] patients treated with oxaliplatin-based chemotherapy.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] genotyping might make tailor chemotherapy possible for [DISEASE]@DISEASE$[/DISEASE] patients treated with oxaliplatin-based chemotherapy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [62, 71], "entity_2_idx_in_text_with_entity_marker": [75, 84], "entity_2_idx_in_text_with_typed_entity_marker": [84, 93], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_60", "text": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and @GENE$ variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of @DISEASE$ (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.", "text_with_entity_marker": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and [E1]@GENE$[/E1] variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of [E2]@DISEASE$[/E2] (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.", "text_with_typed_entity_marker": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and [GENE]@GENE$[/GENE] variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of [DISEASE]@DISEASE$[/DISEASE] (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [110, 116], "entity_1_idx_in_text_with_entity_marker": [114, 120], "entity_1_idx_in_text_with_typed_entity_marker": [116, 122], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_8_16", "text": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and @DISEASE$ in @GENE$ and GPx2 double knockout mice.", "text_with_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and [E1]@DISEASE$[/E1] in [E2]@GENE$[/E2] and GPx2 double knockout mice.", "text_with_typed_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and [DISEASE]@DISEASE$[/DISEASE] in [GENE]@GENE$[/GENE] and GPx2 double knockout mice.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [106, 115], "entity_1_idx_in_text_with_entity_marker": [110, 119], "entity_1_idx_in_text_with_typed_entity_marker": [115, 124], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [119, 125], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_idx_in_text_with_typed_entity_marker": [144, 150], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_8_26", "text": "Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for @GENE$ in @DISEASE$ susceptibility.", "text_with_entity_marker": "Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for [E1]@GENE$[/E1] in [E2]@DISEASE$[/E2] susceptibility.", "text_with_typed_entity_marker": "Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for [GENE]@GENE$[/GENE] in [DISEASE]@DISEASE$[/DISEASE] susceptibility.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [139, 145], "entity_1_idx_in_text_with_entity_marker": [143, 149], "entity_1_idx_in_text_with_typed_entity_marker": [145, 151], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [149, 158], "entity_2_idx_in_text_with_entity_marker": [162, 171], "entity_2_idx_in_text_with_typed_entity_marker": [171, 180], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
